These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15993596)

  • 21. Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.
    Schnatbaum K; Schaudt M; Stragies R; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Zischinsky G
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1233-6. PubMed ID: 20036120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.
    Zischinsky G; Stragies R; Schaudt M; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1229-32. PubMed ID: 20015651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromenones as potent bradykinin B1 antagonists.
    Bryan MC; Biswas K; Peterkin TA; Rzasa RM; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
    Bioorg Med Chem Lett; 2012 Jan; 22(1):619-22. PubMed ID: 22088753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SAR of N-phenyl piperidine based oral integrin alpha5beta1 antagonists.
    Zischinsky G; Osterkamp F; Vossmeyer D; Zahn G; Scharn D; Zwintscher A; Stragies R
    Bioorg Med Chem Lett; 2010 Jan; 20(1):65-8. PubMed ID: 19959360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides.
    Schaudt M; Locardi E; Zischinsky G; Stragies R; Pfeifer JR; Gibson C; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1225-8. PubMed ID: 20015645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
    Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
    J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist.
    Porreca F; Vanderah TW; Guo W; Barth M; Dodey P; Peyrou V; Luccarini JM; Junien JL; Pruneau D
    J Pharmacol Exp Ther; 2006 Jul; 318(1):195-205. PubMed ID: 16565167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.
    Dressen D; Garofalo AW; Hawkinson J; Hom D; Jagodzinski J; Marugg JL; Neitzel ML; Pleiss MA; Szoke B; Tung JS; Wone DW; Wu J; Zhang H
    J Med Chem; 2007 Oct; 50(21):5161-7. PubMed ID: 17880055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepines as potent and selective bradykinin B1 antagonists.
    Wood MR; Kim JJ; Han W; Dorsey BD; Homnick CF; DiPardo RM; Kuduk SD; MacNeil T; Murphy KL; Lis EV; Ransom RW; Stump GL; Lynch JJ; O'Malley SS; Miller PJ; Chen TB; Harrell CM; Chang RS; Sandhu P; Ellis JD; Bondiskey PJ; Pettibone DJ; Freidinger RM; Bock MG
    J Med Chem; 2003 May; 46(10):1803-6. PubMed ID: 12723943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.
    Su DS; Markowitz MK; Murphy KL; Wan BL; Zrada MM; Harrell CM; O'Malley SS; Hess JF; Ransom RW; Chang RS; Wallace MA; Raab CE; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6045-8. PubMed ID: 15546726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
    Kuduk SD; Di Marco CN; Chang RK; Wood MR; Schirripa KM; Kim JJ; Wai JM; DiPardo RM; Murphy KL; Ransom RW; Harrell CM; Reiss DR; Holahan MA; Cook J; Hess JF; Sain N; Urban MO; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    J Med Chem; 2007 Jan; 50(2):272-82. PubMed ID: 17228869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
    Chen JJ; Biswas K
    Prog Med Chem; 2008; 46():173-204. PubMed ID: 18381126
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
    Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
    J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
    Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
    J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspartic acid scaffold in bradykinin B1 antagonists.
    Huszár J; Timár Z; Bogár F; Penke B; Kiss R; Szalai KK; Schmidt E; Papp A; Keseru G
    J Pept Sci; 2009 Jun; 15(6):423-34. PubMed ID: 19378355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.
    D'Amico DC; Aya T; Human J; Fotsch C; Chen JJ; Biswas K; Riahi B; Norman MH; Willoughby CA; Hungate R; Reider PJ; Biddlecome G; Lester-Zeiner D; Staden CV; Johnson E; Kamassah A; Arik L; Wang J; Viswanadhan VN; Groneberg RD; Zhan J; Suzuki H; Toro A; Mareska DA; Clarke DE; Harvey DM; Burgess LE; Laird ER; Askew B; Ng G
    J Med Chem; 2007 Feb; 50(4):607-10. PubMed ID: 17243660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain.
    Campos MM; Leal PC; Yunes RA; Calixto JB
    Trends Pharmacol Sci; 2006 Dec; 27(12):646-51. PubMed ID: 17056130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible common pharmacophore in the non-peptide antagonists of the bradykinin B1 receptor.
    Marceau F
    Trends Pharmacol Sci; 2005 Mar; 26(3):116-8. PubMed ID: 15749155
    [No Abstract]   [Full Text] [Related]  

  • 40. 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.
    Chen JJ; Nguyen T; D'Amico DC; Qian W; Human J; Aya T; Biswas K; Fotsch C; Han N; Liu Q; Nishimura N; Peterkin TA; Yang K; Zhu J; Riahi BB; Hungate RW; Andersen NG; Colyer JT; Faul MM; Kamassah A; Wang J; Jona J; Kumar G; Johnson E; Askew BC
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3384-9. PubMed ID: 21514825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.